Seeking Alpha
 

LifePoint Hospitals, Inc. (LPNT)

- NASDAQ
  • Fri, Jul. 31, 10:09 AM
    • LifePoint Hospitals (LPNT -3.9%) Q2 results: Revenues: $1,270.4M (+21.3%); Salaries and benefits: $606.8M (+24.2%); Supplies: $194.1M (+19.4%); Other operating expenses: $308.7M (+19.5%); Net Income: $46.4M (+18.7%); EPS: $1.00 (+19.0%); Quick Assets: $422.8M (+120.8%).
    • 2015 Guidance: Net Revenue: $5.15B - 5.25B; Adjusted EBITDA: $695M - 720M; Adjusted EPS: $3.75 - 4.06.
    | Comment!
  • Fri, Jul. 31, 7:03 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q2 EPS of $1.00 beats by $0.01.
    • Revenue of $1.27B (+21.0% Y/Y) beats by $30M.
    • Press Release
    | Comment!
  • Thu, Jul. 30, 5:30 PM
  • Mon, Jun. 29, 3:30 PM
    • Becton, Dickinson (BDX +0.3%) upgraded to Buy from undefined with a $167 (18% upside) price target by UBS.
    • Community Health Systems (CYH -0.9%) upgraded to Buy from Neutral with an $83.90 (33% upside) price target by Mizuho Securities.
    • LifePoint Health (LPNT +2.8%) upgraded to Buy from Neutral with a $95.71 (11% upside) price target by Mizuho Securities.
    • UnitedHealth Group (UNH -1.3%) upgraded to Buy from Neutral with a $126 (3% upside) price target by Sterne Agee CRT.
    • Tenet Healthcare (THC -1.5%) upgraded to Outperform from Market Perform with a $64 (12% upside) price target by Wells Fargo.
    • Cepheid (CPHD -1.7%) raised to Buy from Hold with a $75 (25% upside) price target by Craig-Hallum.
    • Merge Healthcare (MRGE -0.1%) upgraded to Buy from Hold with a $5.75 (17% upside) price target by Topeka Capital.
    • Alere (ALR -0.2%) upgraded to Buy from Neutral with a $60 (15% upside) price target by Goldman Sachs.
    • Smith & Nephew (SNN -2.1%) upgraded to Buy from Neutral with a 1275p (16% upside) price target by UBS.
    • Aerie Pharmaceuticals (AERI -4.3%) upgraded to Buy from Hold with a $40 (135% upside) price target by Canaccord Genuity.
    | Comment!
  • Fri, Jun. 26, 5:37 PM
    | 16 Comments
  • Fri, Jun. 12, 12:17 PM
    • AMAG Pharmaceuticals (AMAG -1.5%) initiated with Hold rating and $75 (10% upside) price target by Deutsche Bank.
    • Supernus Pharmaceuticals (SUPN +9.5%) initiated with Buy rating and $30 (70% upside) price target by SunTrust Robinson Humphrey.
    • Plasmatech Biopharmaceuticals (PTBI -2.7%) initiated with Buy rating and $16 (118% upside) price target by Roth Capital.
    • Horizon Pharma (HZNP -0.4%) initiated with Overweight rating and $38 (19% upside) price target by Morgan Stanley.
    • Depomed (DEPO -2.1%) initiated with Equal Weight rating and $23 (10% upside) price target by Morgan Stanley.
    • Community Health Systems (CYH +0.5%) initiated with Outperform rating and $65 (19% upside) price target by Wedbush.
    • HCA Holdings (HCA -0.1%) initiated with Outperform rating and $93 (11% upside) price target by Wedbush.
    • LifePoint Health (LPNT -0.2%) initiated with Neutral rating and $80 (5% upside) price target by Wedbush.
    • HealthSouth (HLS) initiated with Neutral rating and $46 (3% downside risk) price target by Wedbush.
    • Adeptus Health (ADPT -0.4%) initiated with Overweight rating and $106 (26% upside) price target by KeyBanc.
    • Universal Health Services (UHS -0.1%) initiated with Neutral rating and $141 (7% upside) price target by Janney Capital.
    • Owens & Minor (OMI -0.2%) initiated with Sector Perform rating and $35 (3% upside) price target by RBC Capital.
    • Henry Schein (HSIC -0.6%) initiated with Outperform rating and $165 (16% upside) price target by RBC Capital.
    | 5 Comments
  • Tue, Jun. 9, 10:55 AM
    • CVS Health (CVS -0.1%) initiated with Outperform rating and $115 (16% upside) price target by Macquarie.
    • Galapagos (GLPG -3%) initiated with Overweight rating and $73 (36% upside) price target by Morgan Stanley.
    • LifePoint Health (LPNT) initiated with Conviction Buy rating and $92 (25% upside) price target by Goldman Sachs.
    • BioMarin Pharmaceutical (BMRN -2.2%) initiated with Overweight rating and $150 (24% upside) price target by Barclays.
    • Universal Health Services (UHS +0.2%) initiated with Neutral rating and $140 (10% upside) price target by Goldman Sachs.
    • Amsurg (AMSG -0.5%) initiated with Buy rating and $81 (17% upside) price target by Goldman Sachs.
    • Momenta Pharmaceuticals (MNTA -2.6%) initiated with Buy rating and $26 (18% upside) price target by Stifel Nicolaus.
    • Actavis (ACT -0.6%) initiated with Outperform rating and $344 (16% upside) price target by Raymond James.
    | Comment!
  • Mon, May 11, 7:56 AM
    • In order to reflect its evolution from an operator of community hospitals to an broad healthcare services organization, LifePoint Hospitals (NASDAQ:LPNT) changes its name to LifePoint Health.
    • In addition to hospitals, the firm's portfolio of services now includes physician practices, post-acute services, outpatient services and wellness/prevention programs. It operates facilities in more than 60 communities in 20 states, including more than 60 hospitals, 1,100 physician practices, 40 post-acute service providers and 30 outpatient centers.
    | Comment!
  • Fri, May 1, 7:57 AM
    • LifePoint Hospitals (LPNT -1.5%) Q1 results: Revenues: $1,263.7M (+25.5%); Salaries and benefits: $611.2M (+28.7%); Supplies: $196.8M (+25.4%); Other operating expenses: $293.6M (+20.6%); Net Income: $38.9M (+4.9%); EPS: $0.84 (+7.7%); Quick Assets: $281.9M (+47.2%); CF Ops: $179.6M (+65.4%).
    • No guidance given.
    | Comment!
  • Fri, May 1, 7:07 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q1 EPS of $0.84 may not be comparable to consensus of $0.99.
    • Revenue of $1.26B (+24.8% Y/Y) beats by $20M.
    • Press Release
    | Comment!
  • Thu, Apr. 30, 5:30 PM
  • Wed, Mar. 4, 7:21 PM
    • Shares of hospital operators and some managed care providers turned in strong gains today after the U.S. Supreme Court entertained arguments on a case that questioned whether Obamacare health insurance subsidies should be provided in the 34 states that have not set up their own exchanges (transcript).
    • The catalyst come from questions posed by Justice Kennedy - considered a swing vote on the issue - voicing concerns about potential constitutional consequences of a ruling that strikes down the availability of the subsidies.
    • Kennedy said throwing out subsidies would potentially unlawfully pressure states and cause an insurance "death spiral" because premiums would increase, but he also said he had an open mind over the challengers' interpretation of the law.
    • CYH +6.3%, THC +6.2%, HCA +5.8%, LPNT +3.6%, EVHC +3.6%, UHS +2.7%, TMH +2%.
    | 2 Comments
  • Wed, Mar. 4, 12:11 PM
    • Hospitals rally on comments from Supreme Court Justice Anthony Kennedy, often a swing vote in important cases. He says there is a powerful point to the Obama administration's argument that the Affordable Care Act would fall apart if the subsidies were ruled invalid.
    • The Court is currently hearing arguments in the case King v. Burwell, which challenges federal subsidies in states that did not create their own health insurance exchanges. Its final decision will not be announced until June, though.
    • Hospitals and health insurers have the most at stake. They have benefited greatly since the law was signed in 2010. To date, 11.4M Americans have signed up for coverage in 2015, giving both groups more paying customers and potentially cutting the number of non-paying emergency room visits. If the subsidies were ruled invalid then many people would drop coverage due to the higher cost.
    • Related tickers: (HCA +6.2%)(THC +5.4%)(UHS +2.6%)(CYH +5.4%)(LPNT +3.3%)(SEM -0.9%)(SSY)(HUM +0.1%)(CI -0.4%)(CNC)(MOH +0.3%)(ANTM +0.5%)(UNH +0.3%)(MGLN +0.3%)(WCG +0.3%)
    | 17 Comments
  • Thu, Feb. 12, 7:25 AM
    • LifePoint Hospitals (NASDAQ:LPNT): Q4 EPS of $0.48 may not be comparable to consensus of $1.00.
    • Revenue of $1.26B (+32.3% Y/Y) in-line.
    • Press Release
    | Comment!
  • Wed, Feb. 11, 5:30 PM
  • Thu, Feb. 5, 9:04 AM
    • Fourteen of 23 prominent hospitals contacted by Reuters have rolled out pilot programs of Apple's HealthKit service, which enables the remote monitoring of patient-generated health information, such as blood pressure, weight and heart rate, via an iPhone. The technology will potentially enable physicians detect early signs of trouble and to intervene accordingly in patients with chronic diseases like diabetes and hypertension before the situation becomes acute (and much more expensive).
    • Google and Samsung have released similar services and have also begun to reach out to hospitals. This bodes well for patients and doctors alike.
    • Related tickers: (NYSE:HUM) (NYSE:HCA) (NYSE:UHS) (NYSE:CYH) (NASDAQ:LPNT) (NYSE:SEM) (NYSE:ADPT) (NYSEMKT:SSY) (NYSE:THC)
    | Comment!
Visit Seeking Alpha's
LPNT vs. ETF Alternatives
Company Description
LifePoint Health Incis a healthcare company dedicated to Making Communities Healthier. The Company through its subsidiaries provides inpatient, outpatient and post-acute services close to home.
Sector: Healthcare
Industry: Hospitals
Country: United States